Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.30%194.671.2%$552.50m
TSROTESARO, Inc.
0.16%74.2114.4%$550.20m
CELGCelgene Corporation
0.12%68.761.2%$525.72m
GILDGilead Sciences, Inc.
-0.06%67.450.9%$512.93m
BIIBBiogen Inc.
-0.11%319.081.3%$359.12m
ILMNIllumina, Inc.
0.72%325.383.5%$356.81m
REGNRegeneron Pharmaceuticals, Inc.
-0.98%373.912.6%$258.98m
VRTXVertex Pharmaceuticals Incorporated
-1.17%171.741.9%$239.02m
AAgilent Technologies, Inc.
0.43%70.891.5%$238.56m
ALXNAlexion Pharmaceuticals, Inc.
-0.61%113.952.0%$141.38m
SRPTSarepta Therapeutics, Inc.
0.90%123.9015.4%$115.15m
INCYIncyte Corporation
-0.35%65.192.5%$106.04m
EXASExact Sciences Corporation
-0.42%69.2625.3%$101.47m
NKTRNektar Therapeutics
-2.11%35.895.5%$97.96m
EXELExelixis, Inc.
-1.73%20.996.4%$83.45m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.